Telaprevir
Back to searchMolecule Structure
Scientific Name
Telaprevir
Description of the Drug
Telaprevir is an NS3/4A viral protease inhibitor used in combination with other antivirals for the curative treatment of chronic Hepatitis C Virus infections.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB05521
http://www.drugbank.ca/drugs/DB05521
Brand Name(s)
Incivek, Incivo
Company Owner(s)
Vertex Pharmaceuticals Inc
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| Hepatitis C virus serine protease, NS3/NS4A | PROTEIN COMPLEX | INHIBITOR | CHEMBL2095231 |
Clinical Trial(s)
Unichem Links
| SureChEMBL | SCHEMBL183996 | |
| PharmGKB | PA165958354 | |
| Human Metabolome Database | HMDB0015616 | |
| DrugBank | DB05521 | |
| PubChem: Thomson Pharma | 14839657 | 16347884 |
| PubChem | 3010818 | |
| Nikkaji | J2.688.102A | |
| BindingDB | 50326056 | |
| EPA CompTox Dashboard | DTXSID40193304 | |
| DrugCentral | 4173 | |
| Brenda | 7758 | |
| ChemicalBook | CB41519837 | |
| Guide to Pharmacology | 7871 | |
| rxnorm | TELAPREVIR | |
| PubChem: Drugs of the Future | 49684228 | |
| ChEBI | 68595 | |
| ZINC | ZINC000003992480 |
